Market News AIOpen the app

Lakewood-Amedex Biotherapeutics might be removed from Nasdaq because its stock price has been under $1.00 for 30 days.

TroubleRead the original at SEC EDGAR
Bad for LABT

Nasdaq has decided to remove Lakewood-Amedex's shares because its bid stayed below $1 for 30 business days. The hearing request pauses suspension for now, but the company may still lose its listing and says success is not assured.

LABT · Lakewood-Amedex Biotherapeutics Inc.

AI read · Bad for LABT

The AI's read

Nasdaq access matters because losing it could make the shares harder to trade. The company has not yet shown it can meet the listing rule again. Its hearing request pauses suspension, but the panel may reject continued listing. The company also warns that a reverse split may not solve the problem.

Get alerts for LABT

Follow Lakewood-Amedex Biotherapeutics Inc. (LABT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LABT
Free on the App Store and Google Play, or on the web.